Study of RC1416 injection for moderate-to-severe asthma
Part of Lungs & breathing clinical trials.
This study tests a new injected medicine, RC1416, for people with moderate-to-severe asthma that is not well controlled with their current inhalers. It aims to see if the treatment can reduce asthma attacks and improve breathing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have had asthma for at least 1 year.
- You have been using a medium or high dose of inhaled corticosteroids (ICS) for at least 3 months, and your dose has been stable for the past month.
- Your breathing test (FEV1) is less than or equal to 80% of what's expected for someone your age and size.
- You have had at least 1 severe asthma attack in the last 12 months, but not in the past month.
- You have a positive bronchodilator reversibility test, meaning your breathing improves after using a rescue inhaler.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called CM326 for people with moderate to severe asthma that is not well controlled with current treatments. It aims to see if CM326 can help reduce asthma attacks and improve breathing.
This trial tests an injection called RC1416 for people with moderate-to-severe COPD who still have flare-ups despite using triple inhaler therapy. It may help reduce those flare-ups and improve breathing.
This study tests an investigational medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with current treatments. The goal is to see if it can reduce asthma attacks and improve breathing.
This trial tests an experimental drug called SHR-1905 for people with severe asthma that is not well controlled by their current treatments. The study aims to see if the drug can reduce asthma attacks and improve breathing.
This study tests an investigational drug called AK139, given as an injection, to see if it can improve asthma control. It may be an option for people who have had asthma for at least a year and still have symptoms.
This trial tests a new injection, CM512, for people with moderate-to-severe asthma that is not well controlled with current inhalers. It aims to see if the treatment can reduce asthma attacks and improve symptom control.
Hear when a new Moderate to Severe Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.